The global metabolomics market is expected to grow significantly during the forecast period. The study of chemical processes related to metabolites is called metabolomics. The field of metabolomics studies the chemical fingerprints left behind by biological (cellular) processes. Important medical applications of metabolomics include lead compound discovery, lead compound optimization, biomarker identification, and clarity of the drug’s mechanism of action, efficacy, and metabolism.
A full report of Metabolomics Market available at https://www.orionmarketreports.com/metabolomics-market/32193/
The report provides extensive competitive analysis and profiles of key market players operating in metabolomics market, such as Agilent Technologies, Inc., Danaher Corporation, Biocrates Life Sciences AG, Bruker Corporation, LECO Corporation, Metabolon, Inc., Human Metabolome Technologies, Inc., Bio-Rad Laboratories, Inc., Shimadzu Corporation, Waters Corporation, and Thermo Fisher Scientific Inc.
The other players in the market include Kore Technologies, Ltd., Dani Instruments S.P.A., Perkinelmer, Inc., and Evans Analytical Group LLC.
Metabolomics Market Segmentations
By Product & Service
• Metabolomics Instruments
• Metabolomics Bioinformatics Tools & Services
By Application
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Others
By Indication
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
